...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Pretty quiet on the Zenith front,

Zenith AGM is Sept 12th, same day as the Resverlogix AGM. Hopefully a Corporate Update happens along with the Zenith AGM. Notice of meeting and Management Information Circular for AGM should be up on SEDAR soon. So theoretically we'll be hearing something soon.

BearDownAZ

Share
New Message
Please login to post a reply